Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.

Serum beta 2-microglobulin (beta 2-m) is frequently increased in patients with myelomatosis. The possibility that it could provide a biochemical indicator of prognosis was tested in a group of 129 patients from 3 centres, all serum analyses being carried out in one laboratory by radioimmunoassay. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Child, J. A., Crawford, S. M., Norfolk, D. R., O'Quigley, J., Scarffe, J. H., Struthers, L. P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1983
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011252/
https://www.ncbi.nlm.nih.gov/pubmed/6185132

Ejemplares similares

Ejemplares similares